Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Seongnam
Clinical trial register · South Korea

Clinical Trials in Seongnam, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 27 Seongnam 11 Busan 10 Incheon 8 Suwon 6
Narrow the registerReset
Recruitment status
Phase
Site location
Seoul27 Seongnam11 Busan10 Incheon8 Suwon6
All 26 locations
Target enrolment
to

Trials with a site in Seongnam

11 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
Boehringer Ingelheim
Phase 3
466
Bucheon-si, Gyeonggi-do, Busan, Seongnam, Seoul
2026-09-17
Recruiting
Boehringer Ingelheim
Phase 3
400
Goyang, Seongnam, Seoul, Suwon
2026-01-16
Recruiting
Boehringer Ingelheim
Phase 3
120
Daegu, Gwangju, Seongnam, Seoul
2025-12-09
Recruiting
Boehringer Ingelheim
Phase 3
670
Busan, Daejoen, Goyang, Hwasun, Seongnam, Seoul
2025-11-07
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
413
Seongnam, Seoul
2025-09-13
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Ansan-si, Bucheon-si, Busan, Daejeon, Daejoen, Gwangju, Incheon, Seongnam
2025-07-22
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Busan, Gwangju, Incheon, Seongnam, Seoul, Wŏnju
2025-05-20
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bucheon-si, Busan, Cheongju-si, Daejeon, Deagu, Gwangju, Incheon, Seongnam
2024-06-17
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Bucheon-si, Seongnam, Seoul
2024-05-06
Active, closed
Boehringer Ingelheim
Phase 1
554
Chungju, Seongnam, Seoul
2021-07-02
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seongnam

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Seongnam that also match the filters currently applied.

How many clinical trials are recruiting in Seongnam?

7 of the 11 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Seongnam), 11 studies
PhaseStudiesRecruitingShare
Phase 39781.8%
Phase 12018.2%

Most active sponsors

Lead sponsors with the most studies (Seongnam)
Lead sponsorStudiesRecruiting
Boehringer Ingelheim117
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.